Imunon, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31)
Imunon, Inc. (IMNN) had Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) of 16.37 million shares as of 2011-06-30, per its 10-Q filed 2011-08-09.
Discontinued › Notes › Shares
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicAndDiluted · last filed 2011-08-09
- 2011-06-30: Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) 16.37M shares.
- 2010-06-30: Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) 12.23M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) |
|---|---|
| 2011-06-30 | 16.37M shares 10-Q · filed 2011-08-09 |
| 2010-06-30 | 12.23M shares 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |